• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

UnitedHealth Group Acquires Personalized Health Network PatientsLikeMe

Share:

June 25, 2019

UnitedHealth Group has acquired PatientsLikeMe, a personalized health network, according to an email confirmation from CNBC. The acquisition comes off the reports in April that PatientsLikeMe was being forced by Trump administration’s Committee of Foreign investment over its Chinese majority owner Tencent.

Founded in 2004, PatientsLikeMe is the world’s largest personalized health network, helps people find new options for treatments, connect with others, and take action to improve their outcomes. The company has worked with every major pharmaceutical company and a range of government organizations to bring the patient voice to research, development and public policy. With 500,000 members, PatientsLikeMe serves as a trusted source for real-world disease information and a clinically robust resource that has published more than 100 research studies.

“UnitedHealth Group and PatientsLikeMe are committed to using technology and innovation to help people live healthier lives and help make the health system work better for everyone. We look forward to collaborating on patient-first research and building upon the supportive communities patients have come to rely on.”

UHG Plans to PatientsLikeMe

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

UnitedHealth Group plans to integrate PatientsLikeMe with their Research & Development (R&D) arm focused on applying practical innovation to address cost, quality and access to health care – from early-stage research to pilot programs to new business models.

Financial details of the acquisition were not disclosed.

Date: June 25, 2019

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • North American M&A Hits Near-Record Volume in Q2’21 as Resurgence ContinuesNorth American M&A Hits Near-Record Volume in Q2’21 as Resurgence Continues
  • BioVie Announces Closing of Acquisition of Biopharma Assets from Privately Held NeurMedixCompany Expects to Commence Enrollment in Pivotal Phase 3 Alzheimer’s Trial in Mid-2021BioVie Announces Closing of Acquisition of Biopharma Assets from Privately Held NeurMedixCompany Expects to Commence Enrollment in Pivotal Phase 3 Alzheimer’s Trial in Mid-2021
  • Biofourmis Secures $300M to Expand Virtual Care OfferingsBiofourmis Secures $300M to Expand Virtual Care Offerings
  • American Regent, Inc. to Acquire a Daiichi Sankyo Affiliate API Manufacturing Facility in France to Complement Its U.S. ManufacturingAmerican Regent, Inc. to Acquire a Daiichi Sankyo Affiliate API Manufacturing Facility in France to Complement Its U.S. Manufacturing
  • Aspen Surgical Acquires Protek Medical ProductsAspen Surgical Acquires Protek Medical Products
  • Arcadia Acquires Selected Assets of Massachusetts eHealth CollaborativeArcadia Acquires Selected Assets of Massachusetts eHealth Collaborative
  • Merck Animal Health Completes Acquisition of Quantified Ag®Merck Animal Health Completes Acquisition of Quantified Ag®
  • M&A for 2019 was Big; Will 2020 Be Even Bigger?M&A for 2019 was Big; Will 2020 Be Even Bigger?

Trending This Week

  • Denials Management Named Most Time-Consuming Task in RCM
  • Why Adopting Value-Based Care Models for Autism Care Is Imperative
  • Why AI-Driven Cancer Screening Will Soon Become Standard of Care
  • Bioventus Completes Divestiture of its Wound Business
  • Enzo Biochem Reports Significant Progress Toward Completing the Clinical Lab Asset Sale
  • eMolecules Acquires Specs Compound Handling B.V.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications